Found "Public health policy": 1,103 results
Sort by
Last updated

The clinical efficacy and economic evaluation of EC-MPS (Myfortic®) in the treatment of relapse or resistant proliferative lupus nephritis. (in Thai language)

The Clinical Research Collaboration Network in collaboration with the HITAP conducted a clinical test of Randomized Controlled Trial (RCT) regarding the treatment of relapse or resistant proliferative lupus nephritis. The objective of this research was to determine the efficacy of enteric-coated Mycophenolate Sodium combined with corticosteroids fo

Economic evaluation of screening and diagnostic algorithms for pulmonary tuberculosis among people living with HIV/AIDS in Thailand

The Thailand Ministry of Public Health - U.S. Centers for Disease Control and Prevention Collaboration (TUC) in collaboration with partners in Thailand, Cambodia and Vietnam, conducted a clinical study resulting in a new algorithm for pulmonary tuberculosis (PTB) detection. The newly proposed algorithm consists of three initial symptom screening cr

Development and evaluation of communication interventions to prevent suicidal attempts (Phrase l) (in Thai language)

This study is the first stage under the project of development and evaluation concerning the effectiveness of measures to prevent self-harm in Thailand. The problem conditions, involved factors, signals prior to self-harm and measures to prevent self-harm in selected province were studied. The study results illustrate the problems of inaccessibili

Cost-utility analysis of 10- and 13- valent pneumococcal conjugate vaccines in Thailand

A model-based economic evaluation was performed to estimate costs as well as outcomes of vaccination with PCV10 and PCV13 compared to ‘no vaccination’. This study considered two commonly recommended regimens: two-dose primary series at 2 and 4 months of age plus a booster dose at age 13 months (2+1) and three-dose primary series at 2, 4 and 6 m

Economic evaluation and feasibility analysis of using three-drug antiretroviral regimens as the standard regimens for the prevention of mother-to-child transmission of HIV in Thailand (in Thai language)

Zidovudine (AZT) plus single dose nevirapine (AZT+sd-NVP) were provided to pregnant women with HIV infection who have CD4 > 200 cell/mm3 for preventing vertical transmission. However, three-drug regimen is provided to pregnant women with HIV infection regardless CD4 cell count in high resource countries. Mother to child transmission rate in preg

The Suggestion for Research Management in Developing the Emergency Medical Institute of Thailand

This suggestion report aims to present how to manage and utilize the existing researches to policy and how to enhance the research capacity of the EMS agencies201-344-2553

The Evaluation of Outcomes and Determinants of Cervical Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand (in Thai language)

Cervical cancer is the major health problem among Thai women over a decade. There were an attempt to establish cervical cancer screening in Thailand for 40 years in order to reduce its incidence and mortality. Prior to the year 2005, the low coverage rate of the screening was observed. As a result, the cervical cancer screening programme in Thailan

Research for development of health benefit package under universal coverage scheme

Since the Subcommittee for Development of Benefits and Service system under the Universal Coverage Scheme, the National Health Security Office considers that there are health measures not included in the health benefit package under the universal coverage scheme. Some measures are already in the benefits package, but they are expensive and service

Economic evaluation of drug treatments in patients with Chronic Hepatitis B (CHB) (in Thai language)

The objective of this study is to determine the economic evaluation of the treatment of chronic hepatitis B by using drugs that are currently available in Thailand, and to analyze the budget impact in listing drugs with cleared health economic evaluation into the National List of Essential Medicines.  01-340-2552
10 / Page